Evidence map›Paper›PMID 28542220›Full record

ArticlePloS one2017

Expression of receptor-type protein tyrosine phosphatase in developing and adult renal vasculature.

Keiko Takahashi, Rachel Kim, Colette Lauhan, Yuna Park, Nghiep G Nguyen, Dietmar Vestweber, Melissa G Dominguez, David M Valenzuela, Andrew J Murphy, George D Yancopoulos and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Agonistic anti-CD148 monoclonal antibody attenuates diabetic nephropathy in mice.American journal of physiology. Renal physiology · 2020
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Keiko TakahashiDivision of Nephrology and Hypertension, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Rachel KimDivision of Nephrology and Hypertension, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Colette LauhanDivision of Nephrology and Hypertension, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Yuna ParkDivision of Nephrology and Hypertension, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Nghiep G NguyenUniversity of Oklahoma College of Medicine, Oklahoma City, Oklahoma, United States of America.
Dietmar VestweberMax-Planck-Institute of Molecular Biomedicine, Münster, Germany.
Melissa G DominguezRegeneron Pharmaceuticals, Inc., Tarrytown, New York, United States of America.
David M ValenzuelaRegeneron Pharmaceuticals, Inc., Tarrytown, New York, United States of America.
Andrew J MurphyRegeneron Pharmaceuticals, Inc., Tarrytown, New York, United States of America.
George D YancopoulosDepartment of Cancer Biology, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Nicholas W GaleRegeneron Pharmaceuticals, Inc., Tarrytown, New York, United States of America.
Takamune TakahashiDivision of Nephrology and Hypertension, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Vanderbilt University · USRegeneron (United States) · USMax Planck Institute for Molecular Biomedicine · DEUniversity of Oklahoma · US

Funding

TYROSINE PHOSPHATASES IN ENDOTHELIAL GROWTH CONTROLR01DK038517 · NIDDK · VANDERBILT UNIVERSITY · PI TAKAHASHI, TAKAMUNE · 1987 to 2009
$2.8M
Role of CD148 Tyrosine Phosphatase in Diabetic NephropathyR01DK097332 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI TAKAHASHI, TAKAMUNE · 2012 to 2016
$1.7M
Role of CD148 Tyrosine Phosphatase in AngiogenesisR21HL109715 · NHLBI · VANDERBILT UNIVERSITY · PI TAKAHASHI, TAKAMUNE · 2013 to 2014
$424k
NHLBI NIH HHS R21 HL109715NIDDK NIH HHS R01 DK038517NIDDK NIH HHS R01 DK097332
6 · The paper itself

Abstract

Renal vascular development is a coordinated process that requires ordered endothelial cell proliferation, migration, intercellular adhesion, and morphogenesis. In recent decades, studies have defined the pivotal role of endothelial receptor tyrosine kinases (RPTKs) in the development and maintenance of renal vasculature. However, the expression and the role of receptor tyrosine phosphatases (RPTPs) in renal endothelium are poorly understood, though coupled and counterbalancing roles of RPTKs and RPTPs are well defined in other systems. In this study, we evaluated the promoter activity and immunolocalization of two endothelial RPTPs, VE-PTP and PTPμ, in developing and adult renal vasculature using the heterozygous LacZ knock-in mice and specific antibodies. In adult kidneys, both VE-PTP and PTPμ were expressed in the endothelium of arterial, glomerular, and medullary vessels, while their expression was highly limited in peritubular capillaries and venous endothelium. VE-PTP and PTPμ promoter activity was also observed in medullary tubular segments in adult kidneys. In embryonic (E12.5, E13.5, E15.5, E17.5) and postnatal (P0, P3, P7) kidneys, these RPTPs were expressed in ingrowing renal arteries, developing glomerular microvasculature (as early as the S-shaped stage), and medullary vessels. Their expression became more evident as the vasculatures matured. Peritubular capillary expression of VE-PTP was also noted in embryonic and postnatal kidneys. Compared to VE-PTP, PTPμ immunoreactivity was relatively limited in embryonic and neonatal renal vasculature and evident immunoreactivity was observed from the P3 stage. These findings indicate 1) VE-PTP and PTPμ are expressed in endothelium of arterial, glomerular, and medullary renal vasculature, 2) their expression increases as renal vascular development proceeds, suggesting that these RPTPs play a role in maturation and maintenance of these vasculatures, and 3) peritubular capillary VE-PTP expression is down-regulated in adult kidneys, suggesting a role of VE-PTP in the development of peritubular capillaries.

Indexed as

AnimalsEndothelium, VascularKidneyMicePhosphorylationPromoter Regions, GeneticProtein Tyrosine PhosphatasesReceptor Protein-Tyrosine KinasesProtein Tyrosine PhosphatasesReceptor Protein-Tyrosine Kinases

Identifiers

PMID28542220
PMCPMC5444631
OpenAlexW2617375743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.